New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies.

Maixnerova, Dita; El Mehdi, Delphine; Rizk, Dana V; Zhang, Hong; Tesar, Vladimir

Maixnerova, Dita; El Mehdi, Delphine; Rizk, Dana V; Zhang, Hong; Tesar, Vladimir.

Afiliação

Maixnerova D; Department of Nephrology, First Faculty of Medicine, General University Hospital, Charles University, 128 08 Prague, Czech Republic.
El Mehdi D; MorphoSys, MorphoSys US Inc., Boston, MA 02210, USA.
Rizk DV; Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Zhang H; Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing 100034, China.
Tesar V; Department of Nephrology, First Faculty of Medicine, General University Hospital, Charles University, 128 08 Prague, Czech Republic.

J Clin Med ; 11(10)2022 May 16.

Article em En | MEDLINE | ID: mdl-35628935

Palavras-chave

CD38; IgA nephropathy; galactose-deficient IgA1; plasma cells; renal pathology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: República Tcheca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google